相关实验视频
Updated: May 20, 2025

04:20
Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer
Published on: February 9, 2024
853
在子宫腺癌中,CT83通过PDL1的升调促进癌症的进展
Gilhyang Kim1,2, Kyung-Jun Lee3, Eun Shin4
1Department of Pathology, Kangnam Sacred-Heart Hospital, Hallym University Medical Center, Hallym University College of Medicine, Seoul 07441, Republic of Korea.
International journal of molecular sciences
|March 27, 2025
概括
癌症丸抗原CT83促进宫癌的生长和扩散. 高CT83表达与晚期疾病相关,表明它是一个有前途的生物标志物和宫腺癌的治疗标.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 癌症丸抗原 (CTA) 是有前途的生物标志物和瘤学中的治疗点.
- CT83是一种涉及各种癌症的CTA,但它在宫腺癌中的作用需要进一步研究.
研究的目的:
- 研究CT83在宫腺癌进展中的表达和功能作用.
- 评估CT83作为宫癌的潜在诊断标记物和治疗点.
主要方法:
- 定量PCR和西式斑点检测用于评估细胞系中CT83表达.
- 功能性测试 (过度表达和敲击) 来确定CT83对细胞行为的影响.
- 在患者样本上进行免疫组织化学,以将CT83表达与临床参数相关联.
主要成果:
- CT83过度表达增强了宫癌细胞的增殖,迁移,入侵和上皮-介质细胞过渡 (EMT).
- 观察到CT83对PD-L1的上调,这表明它在免疫逃避中发挥了作用.
- CT83在84.9%的宫腺癌病例中得到表达,与较大的瘤大小,升高的SCC抗原和高级FIGO阶段相关.
- 更高的CT83表达与更具侵略性的疾病特征有关.
结论:
- CT83显著促进了宫腺癌的进展和免疫逃避,可能是通过PD-L1调制.
- CT83作为一种潜在的诊断生物标志物和治疗点,可以改善宫癌患者的治疗结果.
相关概念视频
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K

